{
  "documentMetadata": {
    "title": "Diphtheria",
    "sourceFile": "Diphtheria.pdf",
    "lastUpdated": "2025-05-06"
  },
  "content": [
    {
      "type": "header",
      "level": 1,
      "text": "Clinical Setting"
    },
    {
      "type": "nestedContent",
      "content": [
        {
          "type": "paragraph",
          "text": "Presentation:"
        },
        {
          "type": "list",
          "items": [
            "Sore throat, cervical lymphadenopathy, low grade fever, inadequate immunization history for diphtheria"
          ]
        },
        {
          "type": "paragraph",
          "text": "Exam: Erythema progresses to white exudate and then adherent gray pseudomembrane"
        },
        {
          "type": "list",
          "items": [
            "Membrane due to necrosis of mucosal cells by diphtheria toxin",
            "Toxin can also cause damage to myocaridium, kidneys, and central nervous system"
          ]
        },
        {
          "type": "paragraph",
          "text": "Membranous pharyngitis due to Diphtheria may occur in immunized individuals."
        },
        {
          "type": "list",
          "items": [
            "Antibiotics therapy decreases toxin production and reduces spread of organisms."
          ]
        }
      ]
    },
    {
      "type": "list",
      "items": [
        "Respiratory droplet isolation indicated"
      ]
    },
    {
      "type": "nestedContent",
      "content": [
        {
          "type": "paragraph",
          "text": "Diphtheria toxin:"
        },
        {
          "type": "list",
          "items": [
            "Leads to adherent gray membrane in nasal passages, pharynx, and laryngotracheal bronchial tree",
            "Toxin can also cause myocarditis (22%) of patients",
            "Toxin can cause neuropathy (soft palate, cranial nerves)",
            "To obtain equine diphtheria antitoxin from CDC, +1 404-639-2880. More information at CDC Diphtheria pages."
          ]
        }
      ]
    },
    {
      "type": "nestedContent",
      "content": [
        {
          "type": "paragraph",
          "text": "In short:"
        },
        {
          "type": "list",
          "items": [
            "Toxigenic C. diphtheriae primarily causes respiratory track inflammation and necrosis. Treatment is antitoxin and usually parenteral macrolide antibiotic therapy",
            "Non-toxigenic strains of C. diphtheriae, and other invasive Corynebacteriae species, most often manifest as cutaneous ulcers, do not need anti-toxin, and may respond to oral macrolide therapy"
          ]
        },
        {
          "type": "paragraph",
          "text": "See comment section for data on cutaneous ulcers due to non-toxigenic diphtheria"
        }
      ]
    },
    {
      "type": "header",
      "level": 1,
      "text": "Diagnosis"
    },
    {
      "type": "list",
      "items": [
        "Culture of pharynx and nose (alert laboratory as special media needed)",
        "PCR can detect organism and/or C. diphtheriae toxin. CDC can help: phone +1 404-639-1231"
      ]
    },
    {
      "type": "header",
      "level": 1,
      "text": "Etiologies"
    },
    {
      "type": "nestedContent",
      "content": [
        {
          "type": "paragraph",
          "text": "Corynebacterium diphtheriae, toxigenic strains (spread is human to human)"
        },
        {
          "type": "list",
          "items": [
            "Toxigenic strains; spread is human to human",
            "Non-toxigenic strains are a rare cause of serious disease, e.g., bacteremia, endocarditis, osteomyelitis and septic arthritis (MMWR. 2024; 73:405)"
          ]
        }
      ]
    },
    {
      "type": "nestedContent",
      "content": [
        {
          "type": "paragraph",
          "text": "Other Corynebacterium species are rarely toxigenic (spread is animal to human)"
        },
        {
          "type": "list",
          "items": [
            "Corynebacteriuim ulcerans",
            "Corynebacterium pseudotuberculosis"
          ]
        }
      ]
    },
    {
      "type": "header",
      "level": 1,
      "text": "Primary Regimens"
    },
    {
      "type": "list",
      "items": [
        "Place patient in respiratory droplet isolation; Continue isolation until two consecutive cultures, taken at least 24 hrs apart, are negative",
        "Carefully and constantly monitor adequacy of airway. Some patients may need intubation.",
        "Treatment includes antibiotics, antitoxin, and maintenance of patient airway."
      ]
    },
    {
      "type": "nestedContent",
      "content": [
        {
          "type": "paragraph",
          "text": "Antibiotic Therapy:"
        },
        {
          "type": "paragraph",
          "text": "Due to increasing resistance to penicillins, prefer a macrolide as first choice (Genome Med. 2020;12:107)"
        },
        {
          "type": "nestedContent",
          "content": [
            {
              "type": "paragraph",
              "text": "Macrolides"
            },
            {
              "type": "nestedContent",
              "content": [
                {
                  "type": "paragraph",
                  "text": "Azithromycin: (IV/po)"
                },
                {
                  "type": "drugRegimen",
                  "regimenData": {
                    "intent": "treatment",
                    "appliesTo": {
                      "description": "Child"
                    },
                    "components": [
                      {
                        "drug": "Azithromycin",
                        "dose": "10-12 mg/kg",
                        "frequency": "once daily",
                        "notes": "Max. 500 mg/day"
                      }
                    ]
                  }
                },
                {
                  "type": "drugRegimen",
                  "regimenData": {
                    "intent": "treatment",
                    "appliesTo": {
                      "description": "Adult"
                    },
                    "components": [
                      {
                        "drug": "Azithromycin",
                        "dose": "500 mg",
                        "route": "IV/po",
                        "frequency": "once daily"
                      }
                    ]
                  }
                }
              ]
            },
            {
              "type": "nestedContent",
              "content": [
                {
                  "type": "paragraph",
                  "text": "Erythromycin: Child and Adult"
                },
                {
                  "type": "drugRegimen",
                  "regimenData": {
                    "intent": "treatment",
                    "components": [
                      {
                        "drug": "Erythromycin",
                        "dose": "40-50 mg/kg/day (max. of 2 gm/day)",
                        "route": "IV/po",
                        "frequency": "in 4 divided doses"
                      }
                    ],
                    "notes": "If IV, infuse each over 60 minutes"
                  }
                }
              ]
            }
          ]
        },
        {
          "type": "nestedContent",
          "content": [
            {
              "type": "paragraph",
              "text": "Penicillins: Use only if no available macrolides and confirmed in vitro susceptibility"
            },
            {
              "type": "nestedContent",
              "content": [
                {
                  "type": "paragraph",
                  "text": "Child:"
                },
                {
                  "type": "drugRegimen",
                  "regimenData": {
                    "intent": "treatment",
                    "components": [
                      {
                        "drug": "Aqueous Penicillin G",
                        "dose": "100,000-300000 units/kg/day",
                        "route": "IV",
                        "frequency": "divided q6h",
                        "notes": "(max.of 1 million units per dose)",
                        "connector": "or"
                      },
                      {
                        "drug": "Procaine penicillin G",
                        "dose": "50,000 units/kg/day",
                        "route": "IM",
                        "frequency": "once daily",
                        "notes": "(max. of 1.2 million units/ day)",
                        "connector": "or"
                      },
                      {
                        "drug": "Pen V-K",
                        "dose": "10-15 mg/kg/dose (max of 500 mg per dose)",
                        "route": "po",
                        "frequency": "4 times /day"
                      }
                    ]
                  }
                }
              ]
            },
            {
              "type": "nestedContent",
              "content": [
                {
                  "type": "paragraph",
                  "text": "Adult:"
                },
                {
                  "type": "drugRegimen",
                  "regimenData": {
                    "intent": "treatment",
                    "components": [
                      {
                        "drug": "Aqueous Penicillin G",
                        "dose": "25,000 units/kg",
                        "route": "IV",
                        "frequency": "q6h",
                        "notes": "(max 1 million units/dose))",
                        "connector": "or"
                      },
                      {
                        "drug": "Penicillin G procaine",
                        "dose": "1.2 million units",
                        "route": "IM",
                        "frequency": "once daily"
                      }
                    ]
                  }
                },
                {
                  "type": "list",
                  "items": [
                    "Can switch to Penicillin VK 500 mg po without food qid when patient is able"
                  ]
                }
              ]
            }
          ]
        }
      ]
    },
    {
      "type": "nestedContent",
      "content": [
        {
          "type": "paragraph",
          "text": "Diphtheria Antitoxin"
        },
        {
          "type": "list",
          "items": [
            "In USA obtain from the CDC; telephone consultation at: 1-404-639-2889",
            "See WHO Clinical Management Guideline, 2 Feb 2024.",
            "No longer a need for sensitivity testing. If suspected or confirmed sysmptomatic diphtheria administer single dose of antitoxin:"
          ]
        },
        {
          "type": "nestedContent",
          "content": [
            {
              "type": "paragraph",
              "text": "Antitoxin IV therapy. Dose depends on stage of illness:"
            },
            {
              "type": "list",
              "items": [
                "< 48 hours: 20,000-40,000 International units",
                "Presence of nasopharyngeal gray membranes: 40,000-60,000 International units",
                "> 3 days and \"bull neck\": 80,000-120,000 International units. Infuse IV over 60 minutes"
              ]
            }
          ]
        }
      ]
    },
    {
      "type": "nestedContent",
      "content": [
        {
          "type": "paragraph",
          "text": "Close contacts."
        },
        {
          "type": "list",
          "items": [
            "Identify, culture, and manage close contacts. Some will need prophylactic antibiotic:"
          ]
        },
        {
          "type": "nestedContent",
          "content": [
            {
              "type": "paragraph",
              "text": "Treat contacts with Azithromycin 500 mg po once daily x 7-10 days or Erythomycin (dosage above)"
            },
            {
              "type": "paragraph",
              "text": "If no available macrolide, can use Procaine Penicillin G IM: 600,000 units if age < 6 yrs, 1.2 million units if age ",
              "text": "
6 yrs."
            }
          ]
        }
      ]
    },
    {
      "type": "list",
      "items": [
        "Follow up cultures after 1-2 days of therapy and again 2 weeks post end of therapy to document eradication of organism from the airway.",
        "Post therapy, patient will need immunization with diphtheria toxoid vaccine."
      ]
    },
    {
      "type": "header",
      "level": 1,
      "text": "Alternative Regimens"
    },
    {
      "type": "list",
      "items": [
        "No clinical data with other drugs"
      ]
    },
    {
      "type": "header",
      "level": 1,
      "text": "Antimicrobial Stewardship"
    },
    {
      "type": "list",
      "items": [
        "Duration of therapy: typically 14 days",
        "C. diphtheriae is susceptible in vitro to clarithromycin, azithromycin, fluoroquinolones, clindamycin, TMP/SMX, vancomycin and linezolid. If strain resistant to macrolides and penicillin, vancomycin or linezolid are reasonable alternatives",
        "Report of fatal toxigenic C. diphtheriae due to resistance to all beta-lactams to include inducible resistance to carbapenems: Clin Infect Dis 2020; doi.org/10.1093/cid/ciaa1147"
      ]
    },
    {
      "type": "header",
      "level": 1,
      "text": "Comments"
    },
    {
      "type": "list",
      "items": [
        "Azithromycin is better tolerated (both po and IV) than Erythromycin. Erythromycin IV is associated with phlebitis and po with nausea and diarrhea.",
        "Ensure adequate airway. Obtain EKG & cardiac enzymes."
      ]
    },
    {
      "type": "nestedContent",
      "content": [
        {
          "type": "paragraph",
          "text": "Cutaneous diphtheria"
        },
        {
          "type": "list",
          "items": [
            "Chronic shallow ulcer",
            "Presence of dirty gray membrane",
            "Diagnosis by culture or PCR",
            "Corynebacteria strains that cause cutaneous ulcers are usually non-toxigenic, and no antitoxin is needed"
          ]
        }
      ]
    },
    {
      "type": "nestedContent",
      "content": [
        {
          "type": "paragraph",
          "text": "Contact prophylaxis"
        },
        {
          "type": "list",
          "items": [
            "Identify, culture, and consider antimicrobial prophylaxis of close contacts",
            "Immunize if vaccine status is not current or known",
            "Post-cultures: treat contacts with: Azithromycin 500 mg po once daily x 7-10 days"
          ]
        }
      ]
    },
    {
      "type": "list",
      "items": [
        "Disease typically no longer contagious after 48h of therapy.",
        "CDC clinical guidance.",
        "Recent review: StatPearls Publishing; 2022 Jan. 2021 Aug 14"
      ]
    }
  ]
}